To create meaningful change by increasing communication, partnerships and goodwill among stakeholders in the areas of treatment, advocacy, and clinical research with an emphasis on community and advocacy engagement, stigma reduction, and ensuring that clinical research is recognized as a trusted care option.
The Messaging Committee created a series of commercials to address the stigma of mental illness and promote research. These videos are available to Coalition members to use for website, social media, or television spots. We can edit your organizations information to the end of the spots. To see more videos, log into the Community Login and look in the Gallery.
Andrei Pikalov, MD, PhD, Vice President, Head of Global Medical Affairs at Sunovion Pharmaceuticals speaks with The STARR’s Luke Kramer in this episode.
Dr. Pikalov, a licensed & Board Certified psychiatrist, possesses a unique combination of pharmaceutical industry leadership experience with scientific background and clinical expertise. He is a passionate advocate on issues related to patient’s access to new treatment options and has been an active supporter of many initiatives leading to better recognition and treatment of devastating mental disorders. In this podcast, Dr. Pikalov discusses why continued mental health research is critically important in finding treatments – and one day even cures – for mental health disorders.
We recognize that mental health clinical research is a particularly challenging area within research so we’ve brought together stakeholders from pharma, CRO’s, and sites to identify some obstacles and challenges unique to CNS research.
WHY GET STARR CERTIFIED?
One of the STARR Coalition’s favorite advocates is Matthew Shapiro, Associate Director of Public Affairs for NAMI New York State and winner of the distinguished Lew Yagodnik Award for 2020. Matthew’s publicly espoused, unwavering commitment to mental health research has made him a powerful ally in our fight against the stigma of mental health research. […]